Ensysce Biosciences shares are trading higher after the company received a notice of allowance for a U.S. patent titled "COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF"